全球生物晶片市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計生物晶片市場將從 2025 年的 176.5 億美元成長到 2034 年的 472.8 億美元，2026 年至 2034 年的複合年成長率為 11.57%。

全球生物晶片市場正快速成長，其主要驅動力是基因組學、蛋白質組學和個人化醫療等領域的廣泛應用。生物晶片能夠對生物樣本進行高通量分析，已成為疾病診斷、藥物研發和研究活動中不可或缺的工具。慢性病盛行率的上升和生物技術研究投入的增加也顯著推動了市場發展。

關鍵促進因素包括微陣列和晶片實驗室技術的進步，以及政府對醫療創新日益成長的支持。生物晶片能夠提供更快、更準確的診斷結果，這對於精準醫療至關重要。此外，研究機構和生技公司之間的合作正在加速產品開發和商業化進程。

展望未來，隨著即時檢測技術的普及和分子診斷技術的進步，市場有望從中受益。人工智慧（AI）和數據分析的融合將提升分析能力，進而提高治療方案製定的準確性。在持續的技術創新和不斷成長的醫療需求的驅動下，全球生物晶片市場預計將保持持續成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球生物晶片市場：依類型分類

• 市場分析、洞察與預測
• DNA晶片
• 蛋白質晶片
• 晶片實驗室
• 組織陣列
• 細胞陣列

第5章：全球生物晶片市場：依最終用途分類

• 市場分析、洞察與預測
• 生物技術和製藥公司
• 學術研究機構
• 醫院和診斷中心
• 其他

第6章 全球生物晶片市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第7章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第8章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Agilent Technologies
  • PerkinElmer Inc
  • Illumina Inc
  • Bio-Rad Laboratories Inc
  • Standard BioTools
  • GE HealthCare
  • IBIOCHIPS
  • LI-COR Inc
  • Cellix Ltd
  • Randox Laboratories Ltd

The Biochips Market size is expected to reach USD 47.28 Billion in 2034 from USD 17.65 Billion (2025) growing at a CAGR of 11.57% during 2026-2034.

The Global Biochips Market is growing rapidly due to increasing applications in genomics, proteomics, and personalized medicine. Biochips enable high-throughput analysis of biological samples, making them essential in disease diagnosis, drug discovery, and research activities. Rising prevalence of chronic diseases and expanding investments in biotechnology research are contributing significantly to market development.

Key drivers include technological advancements in microarray and lab-on-a-chip technologies, as well as growing government support for healthcare innovation. Biochips provide faster and more accurate diagnostic results, which is crucial in precision medicine. Additionally, collaborations between research institutions and biotechnology companies are accelerating product development and commercialization efforts.

Looking ahead, the market is expected to benefit from the increasing adoption of point-of-care testing and advancements in molecular diagnostics. Integration with artificial intelligence and data analytics will enhance analytical capabilities and improve treatment planning. With continued innovation and expanding healthcare needs, the Global Biochips Market is projected to experience sustained growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• DNA Chips
• Protein Chips
• Lab-on-chip
• Tissue Arrays
• Cell Arrays

By End Use

• Biotechnology And Pharmaceutical Companies
• Academic & Research Institutes
• Hospitals And Diagnostic Centers
• Others

COMPANIES PROFILED

• Agilent Technologies, PerkinElmer Inc, Illumina Inc, BioRad Laboratories Inc, Standard BioTools, GE HealthCare, IBIOCHIPS, LICOR Inc, Cellix Ltd, Randox Laboratories Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOCHIPS MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. DNA Chips Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Protein Chips Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Lab-on-chip Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Tissue Arrays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Cell Arrays Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOCHIPS MARKET: BY END USE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End Use
• 5.2. Biotechnology And Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Hospitals And Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOCHIPS MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Type
  • 6.2.2 By End Use
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Type
  • 6.3.2 By End Use
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Type
  • 6.4.2 By End Use
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Type
  • 6.5.2 By End Use
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Type
  • 6.6.2 By End Use
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL BIOCHIPS INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Agilent Technologies
  • 8.2.2 PerkinElmer Inc
  • 8.2.3 Illumina Inc
  • 8.2.4 Bio-Rad Laboratories Inc
  • 8.2.5 Standard BioTools
  • 8.2.6 GE HealthCare
  • 8.2.7 IBIOCHIPS
  • 8.2.8 LI-COR Inc
  • 8.2.9 Cellix Ltd
  • 8.2.10 Randox Laboratories Ltd